Biosimulation outfit nets $15M Series A in push to make preclinical R&D more predictable

VeriSIM Life has been working on creating a biosimulation platform since its founding in 2017 — and after more than four years and a pre-seed and seed round, the California software firm now has a Series A under its belt.

The $15 million round, led by Morpheus Ventures and supported...

Click to view original post